In this study, we comprehensively evaluated the potential value of serum visfatin in HCC patients, and results indicated that serum visfatin levels were significantly elevated in patients with HCC and were associated with AFP, IL-6, tumor size, and tumor stage. This evidence concerns the gene NAMPT and neoplasm.